🇺🇸 FDA
Pipeline program

Mekinist 2 mg film-coated tablets, Hydroxychloroquine sulfate Accord 200mg film-coated tablets, Mekinist 0.5 mg film-coated tablets

20-27 PaTcH

Phase 2 small_molecule active

Quick answer

Mekinist 2 mg film-coated tablets, Hydroxychloroquine sulfate Accord 200mg film-coated tablets, Mekinist 0.5 mg film-coated tablets for Metastatic refractory Pancreatic Cancer is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Cancer Prevention Pharma (Ireland) Limited
Indication
Metastatic refractory Pancreatic Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials